Introduction {#Sec1}
============

Exercise training after onset of heart attack is important for heart disease patients to improve aerobic capacity. In chronic heart failure (CHF) patients, an improvement of aerobic capacity by exercise training can be explained not only by increased cardiac output in the heart (Dubach et al. [@CR10]), but also increased peak muscle blood flow (Sullivan et al. [@CR33]), increased arterial venous oxygen (O~2~) difference (Dubach et al. [@CR10]), and increased mitochondrial density and oxidative enzyme activity in skeletal muscle (Belardinelli et al. [@CR2]; Minotti et al. [@CR21]; Sullivan et al. [@CR33]). However, the ability for patients to increase peripheral variables associated with aerobic capacity by exercise training soon after myocardial infarction (MI) has not been well established. Previous studies partly demonstrated that an aerobic training intervention improved peripheral factors such as a cross-sectional area of thigh muscle (Murabayashi et al. [@CR23]) and muscle oxidative capacity (Cottin et al. [@CR7]) in early post-MI patients. However, these studies had no control (i.e. non-training) group. It is possible that cardiovascular responses and aerobic capacity may be gradually improved over the natural time course in early after onset of MI patients (Wohl et al. [@CR38]). Therefore, peripheral factors and their relationship to the improvement of aerobic capacity may be altered without exercise training. To strictly test the effect of training in early post heart disease patients, the effect of the natural time course should be also investigated.

The balance between O~2~ delivery and utilization in exercising muscle can be measured noninvasively by near-infrared spectroscopy (NIRS) technique during dynamic exercise (Hamaoka et al. [@CR13]), and the technique has been widely used in the research areas of sports science and exercise physiology. Recently, Takagi et al. ([@CR35]) reported that in early post-MI patients, the absence of muscle deoxygenation measured by NIRS technique was observed during submaximal and peak exercise, and the deoxygenation abnormalities were related to reduced systemic aerobic capacity. To date, it is unclear whether aerobic exercise training improves skeletal muscle deoxygenation abnormalities in early post-MI patients. In addition, changes in muscle deoxygenation through exercise training might be related to improvement of peak aerobic capacity, if exercise training alters muscle deoxygenation. An increase in aerobic capacity reduces cardiovascular-associated morbidity and mortality, as well as an increase in physical activity (Myers et al. [@CR24]). Therefore, an increase in peak aerobic capacity via exercise training is important even for early post-MI patients. Moreover, early initiation of moderate intensity aerobic training may be more beneficial to improve peak aerobic capacity than late initiation (Johnson et al. [@CR16]). Assessing the effects of aerobic training on muscle deoxygenation can be useful and helpful in understanding the increase in peripheral variables and its relation to increased peak aerobic capacity in MI patients. The aim of this study was to investigate the effects of aerobic exercise training on muscle deoxygenation and its relationship to aerobic capacity.

Methods {#Sec2}
=======

Patients {#Sec3}
--------

Inclusion criteria of the subjects were: (1) fewer than 6 weeks after onset of their first heart attack, (2) age between 40 and 75 years old, and (3) ability to perform exercise testing. All participants had received a percutaneous coronary stent as part of their post-MI clinical treatment. Initially, 23 MI patients were recruited between June 2010 and March 2012 from the cardiac rehabilitation center at Tokyo Medical University Hospital. Patients with peripheral vascular disease, post-infarction angina, critical arrhythmia, (unstable) heart failure, or lung disease were excluded. As a result, 16 early post-MI patients (21 ± 8 days after the first MI) were chosen to participate and invited to engage in exercise training. However, 6 of the 16 subjects were unable to participate in exercise training due to their work schedules. The authors decided to exclude them from the training group, and consequently, the 16 MI subjects were divided into an aerobic exercise training (TR, *n* = 10) group and a non-training (CON, *n* = 6) group (Table [1](#Tab1){ref-type="table"}). Mean left ventricular ejection fraction (LVEF) was determined by echocardiography. Peak creatine kinase was measured during the course of their disease. Hemoglobin concentration was measured before exercise testing by blood sampling from the antecubital vein. All medication dosages taken by the MI patients remained stable during the study. Before this study, all patients participated in approximately five sessions of exercise training as part of cardiac rehabilitation in the hospital. A session consisted of cycling exercise for 30 min at the individual's three metabolic equivalents. The study protocol was approved by the Medical Research Ethics Committee of Tokyo Medical University (\#1405) and was conducted in accordance with the Declaration of Helsinki. All subjects were informed of the purpose of the study, and written informed consent was obtained.Table 1Physical and clinical characteristics and medication profilesTR (*n* = 10)CON (*n* = 6)BeforeAfterBeforeAfterAge (years)59 ± 10NA61 ± 9NAHeight (cm)164.9 ± 9.6NA165.5 ± 7.2NAWeight (kg)68.5 ± 13.968.8 ± 13.765.9 ± 12.266.1 ± 12.0Men/women8/2--5/1--Hemoglobin (g dL^−1^)13.1 ± 1.813.9 ± 1.513.5 ± 1.613.8 ± 1.1Number of days after onset of MI20 ± 7NA23 ± 8NALVEF (%)56 ± 655 ± 455 ± 955 ± 9Fat layer thickness at VL (mm)4.86 ± 1.524.90 ± 1.394.57 ± 0.604.55 ± 0.57Peak creatine kinase (IU L^−1^)3674 ± 1472NA3084 ± 2544NASite of MI (%) Anterior60NA67NA Inferior40NA33NANumber of diseased vessels (%) 160NA67NA 220NA17NA 320NA17NAMedication (%) ACE inhibitor70--57-- Angiotensin II receptor antagonist20--14-- Beta-blockers80--71- Calcium channel antagonist30--29 Diuretics30--29 Diabetes (%)10--14-- Dyslipidemia (%)70--71-- Hypertension (%)10--14--*TR* training group, *CON* non-training group, *LVEF* left ventricular ejection fraction, *VL* vastus lateralis, *MI* myocardial infarction, *ACE* angiotensin converting enzyme, *NA* not available, -- no change between before and after intervention

Exercise training {#Sec4}
-----------------

Training frequency was set to two sessions per week for 12 weeks. Each session mainly consisted of cycling exercise for 30 min at the individual's estimated lactate threshold (LT) minus 10 W. Before and after the main cycling exercise, subjects performed stretching for 10 min and cycling at a half of LT minus 10 W for 1 min, as a warm up and cool down. The intensity of cycling training was increased gradually (5 W) over the training period if the heart rate (HR) of estimated LT level attained during baseline exercise testing was not attained during training. All training was monitored by physicians. In CON, none of the subjects were involved in any type of exercise training over the 12 weeks.

Exercise testing (aerobic capacity and cardiorespiratory variables measurement) {#Sec5}
-------------------------------------------------------------------------------

In both groups, exercise testing was administered before and after 12 weeks to evaluate the effects of training. After a 3-min warm up at 10 W, the subjects performed 10 W min^−1^ ramp cycling exercise until exhaustion (Strength Ergo 8, Fukuda-Denshi, Japan). During exercise, pedal frequency of 50 rpm was maintained by keeping time with a metronome, as used in previous studies (Takagi et al. [@CR35]). Subjects were supervised by the investigators, and verbal encouragement was given when needed. All subjects exercised until they could no longer sustain the required cadence. The HR was monitored continuously during the exercise by a 12-lead electrocardiogram (ML-9000 Stress Test System; Fukuda-Denshi, Japan), and pulmonary O~2~ uptake (VO~2~) and carbon dioxide production (VCO~2~) were assessed breath-by-breath (AE310S; Minato Medical Science, Japan) to determine peak VO~2~ and estimated LT, using the V-slope method and substantiated in the profiles of the end-tidal partial pressures of O~2~ and CO~2~, the ventilatory equivalents for VO~2~ and VCO~2~, and respiratory exchange ratio (RER) (Beaver et al. [@CR1]; Takagi et al. [@CR35]; Wasserman et al. [@CR36]). Immediately after maximal exercise, all subjects cycled at 10 W for 3 min. The seat and handlebar height remained constant for each subject in exercise testing before and after training.

VO~2~ response {#Sec6}
--------------

The ∆VO~2~/∆WR slope during ramp exercise was calculated by the linear regression of VO~2~ with work rate, from 4 min after the beginning of the ramp loading up to the point that represented 80 % of the total duration of ramp exercise (Boone et al. [@CR4]; Day et al. [@CR8]). Ideally, the sub-LT region of the response should have been analyzed, however, since the fit was based on only a very small amount of data, it would have become unstable in the ∆VO~2~/∆WR slope. The mean response time (MRT) in VO~2~ during ramp exercise was calculated as the time from onset of the ramp workload to the point of intersection between the baseline VO~2~ during warm up and a backward extrapolation of the VO~2~ vs time slope (Boone et al. [@CR4]; Takagi et al. [@CR35]). The baseline VO~2~ was defined as the mean of VO~2~ during the last 2 min of warm up. For some subjects, workloads 4 min after onset of ramp loading were higher than workloads at estimated LT. Therefore, the whole slope of ∆VO~2~/∆WR and the MRT were calculated using data from six MI patients in TR and four MI patients in CON.

Skeletal muscle deoxygenation measurements {#Sec7}
------------------------------------------

Relative changes from rest in oxygenated hemoglobin/myoglobin concentration (∆oxy-Hb/Mb), deoxygenated hemoglobin/myoglobin concentration (∆deoxy-Hb/Mb) and total hemoglobin/myoglobin concentration (∆total-Hb/Mb), and muscle O~2~ saturation (SmO~2~) were continuously assessed at the belly of the vastus lateralis (VL) muscle in the left leg by near-infrared spatial resolved spectroscopy (NIR~SRS~). The measurement site in VL was defined as 30 % of the length between the patella and the greater trochanter, above the patella (Takagi et al. [@CR34], [@CR35]). The measured signals were defined as the values averaged over the last 10 s at rest, every 20 W, and peak exercise. During the recovery time of re-saturation, the half-recovery time of SmO~2~ (T1/2reoxy) was determined as the time for 50 % reoxygenation of SmO~2~ from the exhaustion level to the peak level (Ichimura et al. [@CR15]). During rest periods without pedaling, subjects sat on the bicycle with the left foot on the pedal, at the lowest position.

In this study, a two-wavelength (770 and 830 nm) light-emitting diode NIR~SRS~ (Astem Co, Japan) was employed. The probe consisted of one light source and two photodiode detectors, and the optode distances were 20 and 30 mm, as were used in previous studies for measuring muscle deoxygenation (Kime et al. [@CR17]; Takagi et al. [@CR35]). The data sampling rate was 1 Hz. Although a previous study demonstrated that fat layer thickness influences NIRS data due to light scattering, the effects of fat layer thickness can be corrected in relative changes in Hb/Mb (Niwayama et al. [@CR25]) or SmO~2~ (Niwayama et al. [@CR26]). The specifications of correction for the influence of fat layer thickness have been fully described (Niwayama et al. [@CR25], [@CR26]). In this study, fat layer thickness at the measurement site of the VL muscles was measured individually before and after intervention, using an ultrasound device (LogiQ3, GE-Yokokawa Medical Systems, Japan). Subsequently, we utilized an NIRS device which had built-in fat-correction software (Astem Co, Japan) and calculated relative changes in Hb/Mb and SmO~2~ with correction for the influence of fat layer thickness, based on individual value of fat layer thickness before and after intervention. Even though an upper limit of fat layer thickness was designated as 10 mm to correct for the light-scattering effects in this study, fat layer thickness at the measurement site was within \~10 mm in all subjects before and after intervention (Table [1](#Tab1){ref-type="table"}).

Statistical analysis {#Sec8}
--------------------

All data are given as mean ± standard deviation. Differences in NIRS, power output, cardiorespiratory variables at peak exercise and estimated LT, VO~2~ response, T1/2reoxy, and demographics variables were analyzed by 2-way repeated-measures analysis of variance (ANOVA) with group and intervention (before--after) as factors. To compare changes in variables during submaximal exercise between before and after intervention over power output and percent of peak VO~2~, 2-way ANOVA was used, with intervention (before--after) and power output and percent of peak VO~2~ as factors. Because one subject could not exercise at more than 62 W before training and 65 W after training, repeated measures between groups were limited to rest, 20, 40, and 60 W compared as a function of power output. As a function of percent of peak VO~2~, differences between groups were determined at rest, 20, 40, 60, and 80 % of peak VO~2~. Similarly, 2-way ANOVA was also adapted to test the baseline condition between groups. Where appropriate, the Bonferroni post hoc test was performed to determine specific significant differences. Pearson's correlation coefficient was employed to determine the relationship between variables. The ANOVA and correlation coefficient were analyzed by SPSS version 17.0 J (SPSS Inc., Chicago, IL). For all statistical analyses, significance was accepted at *p* \< 0.05.

Results {#Sec9}
=======

Exercise training in TR {#Sec10}
-----------------------

Although training frequency was set at two exercise sessions/week for 12 weeks, the subjects exercised 20 ± 3 sessions during the 12-week training period, as their schedules permitted. Initial training intensity (i.e. estimated LT minus 10 W) determined by exercise testing before training was 42 ± 11 W, and the final training intensity was 51 ± 9 W.

Physical and clinical variables (Table [1](#Tab1){ref-type="table"}) {#Sec11}
--------------------------------------------------------------------

There were no significant interactions or significant main effects in any physical or clinical variables between before and after the intervention.

Cardiorespiratory variables {#Sec12}
---------------------------

During submaximal exercise, in TR, there were significant intervention (before--after) × power output interactions for changes in VO~2~ (*p* \< 0.05, Fig. [1](#Fig1){ref-type="fig"}a) and O~2~ pulse (*p* \< 0.05, Fig. [1](#Fig1){ref-type="fig"}c). Even though no significant interactions were observed, a significant main effect of intervention was observed in HR (*p* \< 0.05, Fig. [1](#Fig1){ref-type="fig"}b) and RER (*p* \< 0.05, Fig. [1](#Fig1){ref-type="fig"}d). VO~2~ was significantly higher after training at 20--60 W, and O~2~ pulse was significantly greater after training at rest and 20--60 W. When expressed as a function of peak VO~2~ (i.e. percent of peak VO~2~), there were significant interactions for changes in VO~2~ (*p* \< 0.01) and O~2~ pulse (*p* \< 0.01) in TR. Significantly higher VO~2~ and O~2~ pulse were also observed during submaximal exercise after intervention in TR. In contrast, there were no significant interactions or significant main effects in HR and RER during submaximal exercise. In CON, both expressed as a function of power output and a function of peak VO~2~, no significant changes were found after intervention in any cardiorespiratory variables. Moreover, at baseline, no significant difference was observed between groups in any cardiorespiratory variables during submaximal exercise.Fig. 1Cardiorespiratory responses in TR and CON. Change in oxygen uptake (VO~2~: **a**), heart rate (HR: **b**), oxygen pulse (**c**), and respiratory exchange ratio (RER: **d**) during ramp cycling exercise expressed as a function of power output before (*closed circles*) and after (*open circles*) intervention in exercise training (TR) and non-training groups (CON). Significant difference between before and after intervention during submaximal exercise (\**p* \< 0.05, \*\**p* \< 0.01). Significant difference between before and after intervention at peak exercise (^†^ *p* \< 0.05, ^††^ *p* \< 0.01). Significant intervention (before--after) × power output interaction (^\#^ *p* \< 0.05). Significant main effects of TR (^‡^ *p* \< 0.05). For the sake of clarity, symbols indicating a significant difference between power output before and after intervention have been omitted

At peak exercise, there were significant group × intervention (before--after) interactions for VO~2~ (*p* \< 0.01), O~2~ pulse (*p* \< 0.05), and power output (*p* \< 0.05). In TR, peak VO~2~ (*p* \< 0.01), O~2~ pulse at peak exercise (*p* \< 0.01), and peak power output (*p* \< 0.01) were significantly increased by training compared to before training (Fig. [1](#Fig1){ref-type="fig"}a, c; Table [2](#Tab2){ref-type="table"}), and peak VO~2~ was significantly higher in TR than CON after training (*p* \< 0.05, Table [2](#Tab2){ref-type="table"}). In contrast, there were no significant interactions or main effects in HR and RER at peak exercise. At estimated LT, there were significant group × intervention (before--after) interactions for VO~2~ (*p* \< 0.05) and power output (*p* \< 0.05). In TR, both VO~2~ and power output were significantly increased after training (*p* \< 0.01) at estimated LT (Table [2](#Tab2){ref-type="table"}).Table 2Aerobic capacity and VO~2~ response during ramp exerciseTR (*n* = 10)CON (*n* = 6)BeforeAfterBeforeAfterPeak VO~2~ (mL/kg/min)18.1 ± 3.022.9 ± 2.8^\*\*,\#^18.6 ± 3.818.9 ± 4.6 Power Output (W)99 ± 20119 ± 32\*\*96 ± 12100 ± 19 Heart rate (bpm)132 ± 16136 ± 9132 ± 14138 ± 10Estimated LT VO~2~ (mL/kg/min)11.6 ± 1.614.4 ± 2.4\*\*11.9 ± 4.012.1 ± 3.6 Power Output (W)52 ± 1163 ± 16\*\*52 ± 1153 ± 11VO~2~ response ∆VO~2~/∆WR slope10.3 ± 0.410.3 ± 1.010.8 ± 2.010.6 ± 0.6 Mean response time in VO~2~ (s)83 ± 1461 ± 13\*\*80 ± 2779 ± 20T1/2reoxy (s)31 ± 531 ± 532 ± 1230 ± 10Significant difference between before and after intervention (\* *p* \< 0.05, \*\* *p* \< 0.01)Significant difference between TR and CON (^\#^ *p* \< 0.05)*TR* training group, *CON* non-training group, *VO* ~*2*~ oxygen uptake, *LT* lactate threshold, *WR* work rate, *T1/2reoxy* half-recovery time of muscle oxygen saturation

There was a significant group × intervention (before--after) interaction for MRT (*p* \< 0.05) but not for ∆VO~2~/∆WR slope (*p* = 0.80). The MRT was significantly lower after training than before in TR (*p* \< 0.01), and the MRT tended to be lower in TR than CON after training (*p* = 0.09, Table [2](#Tab2){ref-type="table"}). No significant main effects were found in ∆VO~2~/∆WR slope.

Muscle deoxygenation {#Sec13}
--------------------

Figure [2](#Fig2){ref-type="fig"} shows an example trace of the changes in NIRS variables in real time as the exercise proceeds, with and without fat correction. With fat correction, responses in NIRS variables were somewhat enhanced. Even though SmO~2~ was increased by fat correction, SmO~2~ responses were similar between with and without fat correction in this study.Fig. 2An example trace of the changes in NIRS variables in real time as the exercise proceeds. Changes in muscle oxygen saturation (SmO~2~: **a**), oxygenated hemoglobin/myoglobin (oxy-Hb/Mb: **b**), deoxygenated hemoglobin/myoglobin (deoxy-Hb/Mb: **c**), and total hemoglobin/myoglobin (total-Hb/Mb: **d**) in the vastus lateralis muscle during exercise testing expressed as a function of time (s) with (*solid lines*) and without fat correction (*dashed lines*). The figures show an example trace when fat layer thickness is 6.15 mm. Exercise testing consisted of 1 min rest, 3 min warm up, ramp exercise until exhaustion, and 3 min recovery

During submaximal exercise, in TR, there were significant intervention (before--after) × power output interactions for change in SmO~2~ (*p* \< 0.01, Fig. [3](#Fig3){ref-type="fig"}a) and ∆deoxy-Hb/Mb (*p* \< 0.01, Fig. [3](#Fig3){ref-type="fig"}c), but not in ∆oxy-Hb/Mb (*p* = 0.21, Fig. [3](#Fig3){ref-type="fig"}b) or ∆total-Hb/Mb (*p* = 0.32, Fig. [3](#Fig3){ref-type="fig"}d). Moreover, no significant main effect for training was observed in ∆oxy-Hb/Mb (*p* = 0.18) or ∆total-Hb/Mb (*p* = 0.54) in TR. After training, SmO~2~ was significantly decreased at 40--60 W (*p* \< 0.01) compared to before training. Similarly, ∆deoxy-Hb/Mb was significantly increased after training compared to before at 40--60 W (*p* \< 0.01). We also found significant interactions for changes in SmO~2~ (*p* \< 0.01) and ∆deoxy-Hb/Mb (*p* \< 0.01) in TR when NIRS data was expressed as a function of peak VO~2~, and significantly lower SmO~2~ and higher deoxy-Hb/Mb were obtained during submaximal (40--80 % of peak VO~2~) exercise after intervention in TR. There were no significant interactions or main effects of intervention in ∆oxy-Hb/Mb and ∆total-Hb/Mb as a function of peak VO~2~. In CON, both expressed as a function of power output and a function of peak VO~2~, there were no significant changes after 12 weeks in any NIRS variables. At baseline, no significant differences were found in these variables between TR and CON during submaximal exercise.Fig. 3Muscle deoxygenation in TR and CON. Change in muscle oxygen saturation (SmO~2~: **a**), oxygenated hemoglobin/myoglobin (oxy-Hb/Mb: **b**), deoxygenated hemoglobin/myoglobin (deoxy-Hb/Mb: **c**), and total hemoglobin/myoglobin (total-Hb/Mb: **d**) in vastus lateralis muscle during ramp cycling exercise expressed as a function of power output intensity before (*closed circles*) and after (*open circles*) intervention in exercise training (TR) and non-training groups (CON). Significant difference between before and after intervention during submaximal exercise (\**p* \< 0.05, \*\**p* \< 0.01). Significant difference between before and after intervention at peak exercise (^†^ *p* \< 0.05, ^††^ *p* \< 0.01). Significant intervention (before--after) × power output interaction (^\#\#^ *p* \< 0.01). For the sake of clarity, *symbols* indicating a significant difference between power output before and after intervention have been omitted

At peak exercise, there were significant group × intervention (before--after) interactions for SmO~2~ (*p* \< 0.05) and ∆deoxy-Hb/Mb (*p* \< 0.05), while no significant interactions or main effect were observed in ∆oxy-Hb/Mb and ∆total-Hb/Mb. SmO~2~ at peak exercise was significantly decreased after training than before training in TR (*p* \< 0.01, Fig. [3](#Fig3){ref-type="fig"}a), and consequently, lower SmO~2~ was found in TR than CON after training (*p* \< 0.05). Similarly, ∆deoxy-Hb/Mb at peak exercise was significantly higher after training than before in TR (*p* \< 0.01, Fig. [3](#Fig3){ref-type="fig"}c) and after in CON (*p* \< 0.05).

A significant group × intervention (before--after) interaction for ∆SmO~2~ (SmO~2~ at peak exercise minus SmO~2~ at rest) was found. ∆SmO~2~ was significantly decreased after training in TR (before: 2.4 ± 5.7 %, after: −7.0 ± 3.4 %, *p* \< 0.01) and after intervention in CON (TR: −7.0 ± 3.4 %, CON: 1.1 ± 3.6 %, *p* \< 0.01). There was no significant interaction or main effect in T1/2reoxy (Table [2](#Tab2){ref-type="table"}).

When NIRS variables are expressed without fat correction, similar changes were obtained in all variables. In TR, there were significant interactions for changes in SmO~2~ (*p* \< 0.01) and ∆deoxy-Hb/Mb (*p* \< 0.01), and significantly lower SmO~2~ and higher deoxy-Hb/Mb were observed during submaximal exercise (40 and 60 W) after training. There were no significant interactions or main effects of intervention in oxy-Hb/Mb and total-Hb/Mb. In CON, no significant interactions or main effects of intervention were found in any NIRS variables without fat correction.

Correlation analysis {#Sec14}
--------------------

In all subjects (TR and CON), significant negative relationships were observed between change in ∆SmO~2~ by training and increase in peak VO~2~ (*r* = − 0.85, *p* \< 0.01; Fig. [4](#Fig4){ref-type="fig"}a) and estimated LT (*r* = − 0.77, *p* \< 0.01; Fig. [4](#Fig4){ref-type="fig"}b). Similarly, there were positive relationships between changes in ∆deoxy-Hb/Mb at peak exercise by training and increase in peak VO~2~ (*r* = 0.75, *p* \< 0.01; Fig. [4](#Fig4){ref-type="fig"}c) or increase in estimated LT (*r* = 0.76, *p* \< 0.05; Fig. [4](#Fig4){ref-type="fig"}d). In TR, change in ∆SmO~2~ by training was also significantly negatively correlated with an increase in peak VO~2~ (*r* = − 0.65, *p* \< 0.05) and estimated LT (*r* = − 0.73, *p* \< 0.05). Similarly, significant positive relationships were observed between changes in ∆deoxy-Hb/Mb at peak exercise by training and increase in peak VO~2~ (*r* = 0.64, *p* \< 0.05) or estimated LT (*r* = 0.78, *p* \< 0.01).Fig. 4Relationship between muscle deoxygenation and aerobic capacity. Relationship between change in muscle deoxygenation by intervention and change in aerobic capacity by intervention in TR (*closed circles*) and CON (*open circles*). **a** Change in ΔSmO~2~ (ΔSmO~2~ after intervention minus ΔSmO~2~ before intervention) and change in peak VO~2~ (peak VO~2~ after intervention minus peak VO~2~ before intervention), **b** change in ΔSmO~2~ and change in estimated LT (estimated LT after intervention minus estimated LT before intervention), **c** change in Δdeoxy-Hb/Mb at peak exercise (Δdeoxy-Hb/Mb at peak exercise after intervention minus Δdeoxy-Hb/Mb at peak exercise before intervention) and change in peak VO~2~, **d** change in Δdeoxy-Hb/Mb at peak exercise and change in estimated LT. *ΔSmO* ~*2*~ SmO~2~ at peak exercise minus SmO~2~ at rest, *VO* ~*2*~ oxygen uptake, *LT* lactate threshold

When the influence of light scattering on NIRS variables was not corrected, the relationship was robust. Changes in ∆SmO~2~ without fat correction were significantly negatively correlated with an increase in peak VO~2~ (*r* = − 0.62, *p* \< 0.05) and estimated LT (*r* = − 0.81, *p* \< 0.01). There were significant positive relationships between changes in ∆deoxy-Hb/Mb at peak exercise by training and enhancement of peak VO~2~ (*r* = 0.70, *p* \< 0.01) or estimated LT (*r* = 0.83, *p* \< 0.01).

Workloads of training intensity (W) at end of training (*r* = 0.57, *p* = 0.08), improvement of training intensity (*r* = 0.71, *p* \< 0.05), and training frequency (*r* = 0.71, *p* \< 0.05) were related to the increase in peak VO~2~ by training.

Discussion {#Sec15}
==========

Muscle deoxygenation {#Sec16}
--------------------

After exercise training for 12 weeks in early post-MI patients, skeletal muscle deoxygenation during submaximal and peak exercise was enhanced, while no significant changes were observed in any variables in CON. Because deoxygenation also differed significantly at a given absolute power output, enhancement of deoxygenation is not solely attributed to the increase in maximal power output by training. Aerobic exercise training is confirmed to enhance deoxygenation measured by NIRS technique in healthy subjects (evaluated without a non-training group) (Kime et al. [@CR17]; Prieur and Mucci [@CR29]) and CHF patients (evaluated with a non-training group) (Mezzani et al. [@CR20]). One possible explanation for the enhancement of muscle deoxygenation is the enhancement of muscle O~2~ consumption by aerobic training. Aerobic training increased oxidative enzyme activity in skeletal muscle of MI rats (Moreira et al. [@CR22]). Belardinelli et al. ([@CR2]) reported that aerobic cycling training increased mitochondrial density at VL without improvement of cardiac output in CHF patients. In the present study, SmO~2~ was significantly lower and deoxy-Hb/Mb was significantly higher after training compared to before training, while total-Hb/Mb, which is an indicator of blood volume, was not significantly changed during exercise. Moreover, oxy-Hb/Mb values were decreased after training, even though changes in oxy-Hb/Mb did not reach statistical significance. Although NIRS technique measured the muscle O~2~ balance between supply and utilization, muscle deoxygenation after training in MI may be partly explained by the increase in muscle O~2~ consumption of exercising muscle. Another possibility for enhanced muscle deoxygenation during submaximal exercise is reduced muscle blood flow caused by exercise training, as seen in previous studies of healthy subjects (Saito et al. [@CR32]) and post-MI patients (Clausen and Trap-Jensen [@CR6]). However, VO~2~ during submaximal exercise was significantly higher after training in this study (as described below). Due to the generally positive relationship between muscle blood flow and VO~2~, we suspect that a reduction in muscle blood flow results in higher VO~2~. Taken together, we presume that the enhancement of muscle deoxygenation can be most likely be explained by muscle O~2~ utilization change, rather than flow change, during submaximal exercise.

T1/2reoxy is an index of muscle oxidative capacity, and it also reflects the balance between muscle O~2~ supply and utilization. In this study, no significant changes were observed both in TR and CON. In contrast, in the TR group, peak VO~2~ was significantly increased after intervention. These results suggest that muscle VO~2~ after peak exercise was higher after intervention compared with before in TR, and lead us to speculate that muscle blood flow at peak exercise is also increased by training. However, we should measure muscle blood flow directly in future studies.

Muscle deoxygenation and aerobic capacity {#Sec17}
-----------------------------------------

In early post-MI patients, the effects of aerobic training on peripheral factors and its relation to peak VO~2~ have not been established. Previous studies partly demonstrated that an aerobic training intervention affected a cross-sectional area of thigh muscle (Murabayashi et al. [@CR23]) and muscle oxidative capacity by nuclear magnetic resonance spectroscopy (Cottin et al. [@CR7]), and the changes were related to peak VO~2~ in early post-MI patients. However, these studies did not have a non-training control group. In the TR group of the present study, changes in ∆SmO~2~ and ∆deoxy-Hb were significantly correlated with changes in peak VO~2~ and estimated LT, while no significant difference was observed in either cardiovascular or muscle deoxygenation variables in CON. An increase in aerobic capacity reduces cardiovascular-associated morbidity and mortality (Merz et al. [@CR18]). Therefore, our findings partly support the idea that exercise training may be important for early post-MI patients to improve peripheral functions and aerobic capacity.

VO~2~ is the product of cardiac output (convective O~2~ supply) and O~2~ extraction, and in a strict sense, muscle O~2~ extraction can be estimated by deoxy-Hb/Mb or SmO~2~ when total-Hb/Mb is stable (Ferrari et al. [@CR11]). In this study, total-Hb/Mb increased as power output increased, however, total-Hb/Mb was not different between before and after 12 weeks of intervention. Therefore, the change in deoxy-Hb/Mb and SmO~2~ between before and after training may be partly explained by increasing muscle O~2~ extraction. Okita et al. ([@CR27]) suggested that skeletal muscle dysfunction, rather than cardiac dysfunction, limits exercise tolerance in most patients with CHF. Hence, the strong relationship between change in muscle deoxygenation and increase in peak aerobic capacity in the present study may be attributed to the idea that increasing peak aerobic capacity was mainly caused by increasing muscle O~2~ extraction, rather than cardiac output, during training in early post-MI patients.

Cardiorespiratory variables {#Sec18}
---------------------------

### VO~2~ responses {#Sec19}

The longer MRT may be caused by low muscle O~2~ supply or muscle oxidative capacity (Meyer et al. [@CR19]), and partly results in lower VO~2~ at a given absolute power output (Takagi et al. [@CR35]). In this study, although the longer MRT at baseline was similar to heart disease patients in previous studies (Meyer et al. [@CR19]; Takagi et al. [@CR35]), the 12 weeks of training decreased MRT and increased VO~2~. In fact, previous results demonstrated that, after 6 months of exercise training, leg VO~2~ at a given absolute WR was increased in CHF patients (Hambrecht et al. [@CR14]). Higher VO~2~ after training can be interpreted to mean that cycling efficiency was reduced and/or the contribution of oxidative metabolism was increased (i.e. reduction in contribution of phosphocreatine breakdown and/or glycolysis) (Meyer et al. [@CR19]; Poole et al. [@CR28]; Rossiter [@CR31]; Takagi et al. [@CR35]). However, it seems that the lower VO~2~ before training should not be assumed to be related to higher cycling efficiency in heart disease patients (Poole et al. [@CR28]; Rossiter [@CR31]). Taken together, from the results of the previous studies, aerobic training may increase muscle O~2~ supply and/or muscle oxidative capacity and, consequently, increased contribution of oxidative metabolism in early post-MI patients in this study. However, future studies are needed with a greater number of subjects.

### HR and O~2~ pulse responses {#Sec20}

Lower submaximal HR after TR in this study was a common adaptation of TR, as well as in previous reports of early post-MI patients (Dressendorfer et al. [@CR9]). O~2~ pulse was increased by exercise training, as seen in a previous study of early post-MI patients (Giallauria et al. [@CR12]). Though O~2~ pulse is the product of stroke volume multiplied by arteriovenous O~2~ difference, increased O~2~ pulse with a reduction in HR may lead us to speculate that stroke volume would possibly be increased by training.

Influence of intensity and frequency of training {#Sec21}
------------------------------------------------

In the present study, training intensity in last session and training frequency were positively related to improvement of peak aerobic capacity. Moreover, peak VO~2~ was certainly improved by aerobic training in TR, even though both the training intensity and the frequency are low. These results indicated that both training intensity and frequency are important factors in improving peak aerobic capacity in early post-MI. Recent previous studies demonstrated that high-intensity interval training may be effective to improve aerobic capacity in coronary heart disease patients (Rognmo et al. [@CR30]), and the risk may be the same compared with moderate intensity aerobic training in heart failure patients (Wisløff et al. [@CR37]). However, Blumenthal et al. ([@CR3]) pointed out that "many patients experience subjective discomfort during exercise at high intensity and are therefore dissuaded from pursuing further training, despite its potential benefits". Moreover, to our knowledge, a risk of high-intensity interval training is unknown in early post-MI patients. Therefore, we presume that frequent aerobic training seems to be one of the best options to improve aerobic capacity in early post-MI patients for now, even if the benefits are not ideal.

Study limitations {#Sec22}
-----------------

We recognize the absence of direct measurement, such as muscle blood flow, cardiac output during exercise, or muscle biopsy, to support our findings. Secondarily, the number of subjects is quite low, especially women. Our findings should be confirmed in a larger group of subjects. Moreover, the subjects in this study were not divided randomly into TR or CON. Thus, some sampling bias cannot be ruled out. In addition, our subjects included patients treated with medications. However, our findings cannot be solely attributed to these medications, because the dosages remained stable throughout the study. Furthermore, there are some general limitations of NIRS technique (Hamaoka et al. [@CR13]). NIRS data reflects tissue oxygenation in arterioles, capillaries, and venules of localized exercising muscle, especially in the superficial region of the muscle. The deoxygenation measured by NIRS was heterogeneous between muscles and also within a single muscle (Takagi et al. [@CR34]). Hence, the muscle deoxygenation in early post-MI patients may be restricted to the superficial region of the distal site of the VL muscle. Because muscle recruitment affects the changes in NIRS variables during ramp cycling exercise (Chin et al. [@CR5]), it may be that central attenuation or inhibition of muscle activity in the superficial region of the distal site of the VL muscle is responsible for the changes observed in NIRS dynamics. In particular, post-MI patients in this study had substantially preserved LVEF even before training, and the effect of training on deoxygenation may be influenced by the previously preserved LVEF. Furthermore, in early post-MI patients, aerobic capacity may be increased by very light intensity exercise such as physical activity (Dressendorfer et al. [@CR9]). Though none of the subjects in CON were involved in training over the 12 weeks, we did not regulate their usual physical activity. Future studies are needed which include measurement of physical activity.

Conclusions {#Sec23}
===========

Aerobic exercise training enhanced skeletal muscle deoxygenation during exercise in early post-MI patients. Moreover, the enhancement of muscle deoxygenation by aerobic exercise training may be related to an increase in aerobic capacity in early post-MI patients.
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